Last week the ACIP made a recommendation to administer the 2nd and 3rd dose of HepB vaccine only if serology shows Ab titers below the protective threshold.
This approach has not been approved by the FDA. It wasn't studied in trials. And it's dumb.
The FDA would never have let this fly before.
December 9, 2025 at 10:36 PM
Last week the ACIP made a recommendation to administer the 2nd and 3rd dose of HepB vaccine only if serology shows Ab titers below the protective threshold.
This approach has not been approved by the FDA. It wasn't studied in trials. And it's dumb.